rs199736219
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001083961.2(WDR62):c.3514+1G>A variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000229 in 1,613,530 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001083961.2 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152134Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000959 AC: 24AN: 250250Hom.: 0 AF XY: 0.0000664 AC XY: 9AN XY: 135456
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461396Hom.: 0 Cov.: 34 AF XY: 0.0000151 AC XY: 11AN XY: 727040
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152134Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74314
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 31589614, 20729831) -
- -
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 437291). This variant has not been reported in the literature in individuals affected with WDR62-related conditions. This variant is present in population databases (rs199736219, gnomAD 0.04%). This sequence change affects a donor splice site in intron 29 of the WDR62 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in WDR62 are known to be pathogenic (PMID: 20729831). -
Microcephaly 2, primary, autosomal recessive, with or without cortical malformations Pathogenic:2
The invariant splice donor c.3514+1G>A variant in WDR62 gene has not been reported previously as a pathogenic variant nor a benign variant, to our knowledge. The c.3514+1G>A variant has been reported with allele frequency of 0.01% in gnomAD Exomes and is novel not in any individuals in 1000 Genomes. This variant has been reported to the ClinVar database as Likely Pathogenic / Pathogenic. Loss of function variants in WDR62 have been previously reported to be pathogenic Bilgüvar K, et al., 2010. However, additional functional studies will be required to prove the pathogenicity of this variant. For these reasons, this variant has been classified as Likely Pathogenic. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at